Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02229565 · ClinicalTrials.gov registry record
Molecular Mechanisms Underlying Prostate Cancer Disparities
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 226
- Enrollment target
NCT02229565 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 226 participants.
The verdict
NCT02229565 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 226 participants
- Enrollment target
Study Summary
The purpose of this study is to further elucidate the molecular mechanisms underlying prostate cancer disparities. In previous work the investigators have identified a set of differentially deregulated genes in African American versus Caucasian American prostate cancer. Based on these findings, they hypothesize that they will be able to validate these targets, originally identified in the previous work conducted at The George Washington University Medical Center, in an independent Duke University Medical Center cohort of prostate cancer specimens. In addition, the investigators hypothesize that they will be able to discover novel targets in the Duke University Medical Center cohort of prostate cancer specimens because of regional differences.
Interventions
- DEVICE Biopsy or prostatectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-10-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02229565
The ClinicalTrials.gov registry entry for NCT02229565 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biopsy or prostatectomy is the first listed.
NCT02229565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02229565 about?
NCT02229565 is a clinical study titled "Molecular Mechanisms Underlying Prostate Cancer Disparities". The purpose of this study is to further elucidate the molecular mechanisms underlying prostate cancer disparities. In previous work the investigators have identified a set of differentially deregulated genes in African American versus Caucasian American prostate cancer. Based on these findings, they...
What is the current status of trial NCT02229565?
This trial is currently completed. The enrollment target is 226 participants. The study started on 2014-11. Estimated completion is 2019-10-14.
What interventions are being tested in trial NCT02229565?
The interventions under investigation include: Biopsy or prostatectomy (DEVICE).
Who is sponsoring clinical trial NCT02229565?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.